As of December 26, 2021, a total of 117,920 reports of suspected adverse events following the anti-Covid vaccination were entered in the National Pharmacovigilance Network out of a total of 108,530,987 vaccine doses, with a reporting rate of 109 reports per 100,000 doses administered, independently vaccine and dose.
83.7% (98.717) of the reports entered refer to non-serious events and 16.2% (19,055) to serious adverse events.
This was highlighted by the 'Annual report on the safety of anti-COVID vaccines - 19 27/12/2020 - 26/12/2021' of the Italian Medicines Agency (Aifa).
Vaccination for Covid-19 "is indicated in both pregnancy and lactation
and no particular safety problems emerge from pharmacovigilance data and ad hoc studies in this population. There is also no evidence to suggest that anti-Covid-19 vaccines can negatively affect fertility in both sexes, "says the Italian Medicines Agency.
The need to vaccinate this population in light of the risks associated with the onset of Covid for the mother or fetus "appeared evident - says Aifa".
In the pediatric population,
the most frequently reported adverse events from Covid vaccination are
fever, headache, fatigue and vomiting.
: 69% of reactions in the pediatric population resolved completely or were improving at the time of reporting.
Reporting rates in the 5-11 age group are preliminary and no particular safety concerns are currently emerging.
This was highlighted by the 'Annual report on the safety of anti-COVID vaccines - 19 27/12/2020 - 26/12/2021' of the Italian Medicines Agency (Aifa).
In Italy, the data made available by the Istituto Superiore di Sanità show a total of over 263,000 cases of infection in children aged 6-11 years since the beginning of the pandemic (data updated to 1 December 2021): 1,453 were hospitalized in hospital (hospitalization rate 6 / 1,000), of which 36 in intensive care (1 / 7,000) and 9 died.